4 ms·
Great, but I'm skeptical of any of these "breakthroughs" ever seeing any added value for those who actually need these. Filed under [in mice].
by celdon25 3y ago
Great, but I'm skeptical of any of these "breakthroughs" ever seeing any added value for those who actually need these. Filed under [in mice].
- DoreenMichele 3y agoYears ago, back when I participated on CF health lists, someone said "My child with CF turns 18 today. When he was born, life expectancy for CF was 18. It is now 36." Since then, several CFTR modulators have become available, which are game changing for many people. I see no reason for your skepticism.
- stubybubs 3y agoSome of our biggest breakthrough started with "in mice." Muromonab was the first monoclonal antibody approved by the FDA and came from mice. While the original had some pretty bad side effects, the entire class of biologics came from this and is capable of treating a wide variety of conditions, including essentially stopping the progression of some devastating diseases like ankylosing spondylitis and rheumatoid arthritis.